Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Elanco Animal Health USA
WARNING LETTER
•Elanco Animal Health USA•January 8, 2026

Elanco Animal Health USA – FDA Warning Letter, Jan 8, 2026

Record Details

On January 8, 2026, the U.S. Food and Drug Administration (FDA) issued a Warning Letter to Elanco Animal Health USA, citing false and misleading promotional claims for their product, Pradalex (pradofloxacin injection). The FDA reviewed various promotional communications, including print advertisements, detail aids, a technical manual, and videos, noting issues with the representation of the product"s safety and effectiveness. The main violations included recommending Pradalex for “First-pull treatment” of Bovine Respiratory Disease (BRD) and Swine Respiratory Disease (SRD), which contradicts the FDA-approved label stating it should only be used after considering non-fluoroquinolone options due to critical antimicrobial resistance concerns. Furthermore, Elanco falsely claimed Pradalex was “Effective for the treatment of all relevant BRD pathogens” and “all relevant SRD pathogens,” overstating its approved indications and potentially promoting prohibited extralabel use. Lastly, comparative claims like “2x the power in less than half the time” were found misleading, as they implied general effectiveness and rapid treatment based on in vitro data rather than clinical outcomes. These promotional practices led to the product being misbranded under sections 502(a), 502(n), and 201(n) of the Federal Food, Drug, and Cosmetic Act. Elanco is required to submit a written response within fifteen working days, detailing a plan to discontinue the non-compliant communications or cease Pradalex distribution, and addressing the identified concerns.

Company
Elanco Animal Health USA
Inspection date
January 8, 2026
Product type
Veterinary
Office
Center for Veterinary Medicine
People
  • Jeffrey Simmons
  • Linda Walter-grimm
View Company Profile

ID · fecdb21f-0375-4721-965c-13179116fb37

Violation Codes10
FD&C Act 502(a)21 U.S.C. 352(a)FD&C Act 502(n)21 U.S.C. 352(n)FD&C Act 201(n)21 U.S.C. 321(n)21 CFR 202.1(e)(5)FD&C Act 301(a)21.U.S.C. 331(a)21 CFR 530.4

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Elanco Animal Health USA
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.